Reuters Health Report

Click to View in Browser 05/15/2014 Promising cancer drug data helps AstraZeneca in Pfizer fight (Reuters) - New data showing an experimental AstraZeneca lung cancer drug shrank tumors in more than half of patients gave the British group fresh ammunition to argue that Pfizer's takeover offer undervalues it substantially. Eli Lilly loses UK Alimta patent case to Actavis LONDON (Reuters) - Eli Lilly and Co LLY.N said on Thursday it lost a patent case in the English High Court over its blockbuster Alimta lung cancer drug to generic drugmaker Actavis Plc ACT.N. Breakfast cereals loaded with too much sugar for U.S. kids: report (Reuters) - U.S. children are consuming more than 10 pounds (4.5 kgs) of sugar annually if they eat a typical morning bowl of cereal each day, contributing to obesity and other health problems, and cereal makers and regulators are doing little to address the issue, according to a study released on Thursday. AstraZeneca leaves door ajar to Pfizer, despite hurdles LONDON (Reuters) - AstraZeneca's boss said on Wednesday he would engage with Pfizer if the price was right and the risks posed from forcing the British drugmaker's operations into the U.S. company's new three-unit model were addressed. U.S. court dismisses Teva case to block copies of Copaxone (Reuters) - A U.S. district court dismissed a case by Teva Pharmaceutical Industries Ltd against the U.S. Food and Drug Administration, part of the Israeli company's broad legal battle aimed at stopping generic versions of its Copaxone drug for multiple sclerosis. U.S. health officials urge use of HIV pill for at-risk individuals CHICAGO (Reuters) - U.S. health officials on Wednesday issued new recommendations urging healthcare workers to consider offering an HIV prevention pill to healthy individuals who are at substantial risk for HIV infection. Reckitt Benckiser to develop XenoPort alcohol abuse drug LONDON (Reuters) - Reckitt Benckiser Group's pharmaceuticals unit will develop and sell XenoPort Inc's drug to treat alcohol use disorders, the companies said on Thursday. Maternal smoking tied to inhibition-related brain differences in kids NEW YORK (Reuters Health) - Smoking while pregnant may be linked to less control over inhibitions when the child is an adult, a new study that looked at brain scans suggests. New lung cancer screening guidelines could cost Medicare $9.3 billion CHICAGO (Reuters) - A study of Medicare beneficiaries with a history of heavy smoking found that new lung cancer screening guidelines would likely double the proportion of lung cancers found at an early stage, but at a steep cost of some $9.3 billion over five years, U.S. researchers said on Wednesday. Bristol, Merck, Roche immune therapies are cancer meeting focus (Reuters) - When the world's leading cancer doctors meet in Chicago next month, new treatments from Merck & Co, Bristol-Myers Squibb Co and Roche Holding AG that help the immune system fight disease are expected to capture much of the spotlight. Related Video Magic carpet lights the way for informative floors Antarctic ice loss "passed the point of no return": scientists The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend